MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas

Kati Kampjarvi, Netta Makinen, Miika Mehine, Salla Valipakka, Outi Uimari, Esa Pitkanen, Hanna-Riikka Heinonen, Tuomas Heikkinen, Jaana Tolvanen, Anne Ahtikoski, Norma Frizzell, Nanna Sarvilinna, Jari Sjoberg, Ralf Butzow, Lauri A. Aaltonen, Pia Vahteristo

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalBritish Journal of Cancer
Volume114
Issue number12
Pages (from-to)1405-1411
Number of pages7
ISSN0007-0920
DOIs
Publication statusPublished - 14 Jun 2016
MoE publication typeA1 Journal article-refereed

Fields of Science

  • FH
  • MED12
  • HLRCC
  • uterine leiomyoma
  • 2SC
  • succination
  • RENAL-CELL CANCER
  • HEREDITARY LEIOMYOMATOSIS
  • FIBROIDS
  • TUMORS
  • GENE
  • 3123 Gynaecology and paediatrics
  • 3122 Cancers
  • 3111 Biomedicine

Cite this